VolitionRX Ltd (VNRX):企業の財務・戦略的SWOT分析

◆英語タイトル:VolitionRX Ltd (VNRX) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDME321317FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥88,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥133,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
VolitionRX Ltd (VolitionRX) is a medical equipment provider that develops diagnostics tests for cancer and other conditions. The company develops Nucleosomics, a platform technology used for measurement and identification of nucleosomes in the blood. It develops tools for the diagnosis of various conditions including colorectal cancer, prostate and lung cancers, and inflammatory and other diseases. VolitionRX also conducts research and development, and offers clinical trial services. The company has collaboration with hospital, medical center, universities and research institute. It operates in Belgium, Singapore, the UK and the US. VolitionRX is headquartered in Singapore City, Singapore.

VolitionRX Ltd Key Recent Developments

Mar 30,2021: VolitionRx Limited Appoints Dr. Tom Butera DVM as Chief Executive Officer for Volition Veterinary Subsidiary
Mar 29,2021: VolitionRx appoints two new directors
Mar 22,2021: VolitionRx announces Full Fiscal Year 2020 Financial Results and Business Update
Mar 16,2021: VolitionRx Schedules Full Fiscal Year 2020 Earnings Conference Call and Business Update
Mar 08,2021: VolitionRx Limited to Present at Conferences in March 2021

This comprehensive SWOT profile of VolitionRX Ltd provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of VolitionRX Ltd including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

VolitionRX Ltd – Key Information
VolitionRX Ltd – Overview
VolitionRX Ltd – Key Employees
VolitionRX Ltd – Key Employee Biographies
VolitionRX Ltd – Key Operational Heads
VolitionRX Ltd – Major Products and Services
VolitionRX Ltd – History
VolitionRX Ltd – Company Statement
VolitionRX Ltd – Locations And Subsidiaries
VolitionRX Ltd
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

VolitionRX Ltd – Business Description
VolitionRX Ltd – Corporate Strategy
VolitionRX Ltd – SWOT Analysis
SWOT Analysis – Overview
VolitionRX Ltd – Strengths
VolitionRX Ltd – Weaknesses
VolitionRX Ltd – Opportunities
VolitionRX Ltd – Threats
VolitionRX Ltd – Key Competitors

Section 3 – Company Financial Performance Charts

VolitionRX Ltd – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

VolitionRX Ltd, Key Information
VolitionRX Ltd, Key Ratios
VolitionRX Ltd, Share Data
VolitionRX Ltd, Major Products and Services
VolitionRX Ltd, History
VolitionRX Ltd, Key Employees
VolitionRX Ltd, Key Employee Biographies
VolitionRX Ltd, Key Operational Heads
VolitionRX Ltd, Other Locations
VolitionRX Ltd, Subsidiaries
VolitionRX Ltd, Key Competitors
VolitionRX Ltd, SWOT Analysis
VolitionRX Ltd, Ratios based on current share price
VolitionRX Ltd, Annual Ratios
VolitionRX Ltd, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[VolitionRX Ltd (VNRX):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Esab Holdings Ltd
    Esab Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Esab Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Cell Medica Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Cell Medica Ltd (Cell Medica), formerly Immunocode Ltd manufactures and commercializes cellular products. The company uses various technology platforms such as chimeric antigen receptor (CAR), Dominant T cell receptor (TCR), PENTRA Antibody technology and NKT cell platform for manufacturing …
  • UniQuest Pty Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary UniQuest Pty Ltd (UniQuest), a subsidiary of The University of Queensland is a commercialization company that offers consultancy services. The company commercializes intellectual property and research outcomes of University of Queensland. It offers services such as eShop, witness, contract r …
  • PhoenixBio Co Ltd (6190)-製薬・医療分野:企業M&A・提携分析
    Summary PhoenixBio Co Ltd (PhoenixBio) is a life science company that offers medical therapy solutions. The company offers contract study services which include dosing of test-compounds, sampling, in-life phase trials, chemical analysis, measurement of human albumin levels, and metabolic enzymes and …
  • Blueberry Therapeutics Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Blueberry Therapeutics Ltd (Blueberry Therapeutics) is a provider of nano medicines for the treatment of dermatological disorders. Its pipeline product portfolio includes BB2603-NCE, developed to treat onychomycosis and associated tinea pedis; BB2312 used for the treatment of Acne diseases, …
  • RISE Life Science Corp:企業のM&A・事業提携・投資動向
    RISE Life Science Corp - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's RISE Life Science Corp Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions …
  • Sumo Group PLC (SUMO):企業の財務・戦略的SWOT分析
    Sumo Group PLC (SUMO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Promethera Biosciences SA:製薬・医療:M&Aディール及び事業提携情報
    Summary Promethera Biosciences SA (Promethera) is a developer of cell therapy products for the treatment of liver diseases. The company provides products which are developed on its proprietary progenitor cell type. It offers products such as promethera hepastem and promethera hepascreen, among other …
  • Weyerhaeuser Co (WY):企業の財務・戦略的SWOT分析
    Weyerhaeuser Co (WY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Jiangsu Expressway Co Ltd (600377):企業の財務・戦略的SWOT分析
    Summary Jiangsu Expressway Co Ltd (Jiangsu Expressway) is a highway development company that offers services in investment, construction, operation and management of toll expressways within Jiangsu province. The company offers services such as geographical services, service area development, express …
  • Quadrise Fuels International Plc (QFI):石油・ガス:M&Aディール及び事業提携情報
    Summary Quadrise Fuels International Plc (QFI), previously Zareba Plc, is an oil-in-water emulsified fuel developer that manufactures and markets MSAR (Multi phase Superfine Atomized Residue), an emulsion fuel as a low cost substitute for conventional heavy fuel oil (HFO) for use in power generation …
  • Duke Energy Ohio Inc:企業の戦略的SWOT分析
    Duke Energy Ohio Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • OMRON Corporation:企業の戦略・SWOT・財務情報
    OMRON Corporation - Strategy, SWOT and Corporate Finance Report Summary OMRON Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • GfK SE:企業のM&A・事業提携・投資動向
    GfK SE - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's GfK SE Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital rais …
  • Marks and Spencer Group plc (MKS):企業の財務・戦略的SWOT分析
    Marks and Spencer Group plc (MKS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • China General Nuclear Power Corp:電力:M&Aディール及び事業提携情報
    Summary China General Nuclear Power Corp (CGN), formerly China Guangdong Nuclear Power Group (CGNPC) is a clean energy company that offers clean energy products and renewable energy services. The company's products include nuclear power and HPR1000, among others. It offers services such as nuclear p …
  • Rostelecom:企業の戦略・SWOT・財務情報
    Rostelecom - Strategy, SWOT and Corporate Finance Report Summary Rostelecom - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Stealth BioTherapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Stealth BioTherapeutics Inc (Stealth), formerly Stealth Peptides Inc is a clinical stage biopharmaceutical company that develops therapies to treat mitochondrial dysfunction associated with genetic mitochondrial diseases and common diseases of aging. The company offers elamipretide, a mitoch …
  • Inretail Peru Corp. (INRETC1):企業の財務・戦略的SWOT分析
    Inretail Peru Corp. (INRETC1) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Sirenas LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary Sirenas LLC (Sirenas), formerly Sirenas Marine Discovery LLC, is a biotechnology company that discovers therapeutics derived from nature's chemistry. The company’s proprietary data mining technologyATLANTIS uses data mining and machine learningapproach to uncover the therapeutic potential of …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆